Corporate Moves: Curaleaf has launched a hostile takeover bid for Aurora Cannabis, offering $4 per Aurora share (cash + stock) and signaling a major shake-up for investors watching consolidation in the cannabis market. Public Health: A CDC report finds ED visits for cannabis hyperemesis syndrome jumped after a new CHS-specific ICD-10 code took effect in Oct. 2025, pointing to a likely undercount of CHS before. Medical Research: Lab studies suggest some cannabinoids may make glioblastoma cells less vulnerable to chemotherapy and radiation, raising fresh questions about how CBD/other compounds could interact with cancer treatment. Regulation & Retail: Nevada City is set to revisit cannabis rules, including easing limits on temporary events and allowing more flexibility for delivery-only retail and consumption-lounge setups. Local Industry Spotlight: Noiré Dispensary is rolling out a curated, education-forward menu plus expanded delivery across New Jersey counties, leaning into “plain language” cannabis science for shoppers. Aviation & Drug Testing: India’s aviation probe into an Air India Phuket–Delhi incident includes reports the pilot tested positive for marijuana in a confirmatory test, with crew pulled from flying duties pending investigation.